Daisuke Shibahara

Higashi, 8128582, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

COPD is associated with poorer survival in patients with advanced non-small cell lung cancer treated with first-line ICI plus chemotherapy.

COPD is associated with poorer survival in patients with advanced non-small cell lung cancer treated with first-line ICI plus chemotherapy.

Journal: BMC pulmonary medicine

Published: April 04, 2026

Association of TP53 gain-of-function mutations with early osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma.

Association of TP53 gain-of-function mutations with early osimertinib resistance in epidermal growth factor receptor-mutant lung adenocarcinoma.

Journal: ESMO open

Published: June 06, 2025

Remarkable response to crizotinib in a patient with advanced lung adenocarcinoma harboring the MPRIP-ROS1 fusion gene: A case report.

Remarkable response to crizotinib in a patient with advanced lung adenocarcinoma harboring the MPRIP-ROS1 fusion gene: A case report.

Journal: Respiratory medicine case reports

Published: March 26, 2025

IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancer.

IFITM3-MET interaction drives osimertinib resistance through AKT pathway activation in EGFR-mutant non-small cell lung cancer.

Journal: Molecular cancer

Published: February 25, 2025

Renal dysfunction during osimertinib treatment in patients with non-small cell lung cancer positive for EGFR mutations.

Renal dysfunction during osimertinib treatment in patients with non-small cell lung cancer positive for EGFR mutations.

Journal: Respiratory investigation

Published: December 12, 2024

Enhanced HER2 internalization by clathrin-dependent endocytosis in non-small cell lung cancer positive for HER2 mutations.

Enhanced HER2 internalization by clathrin-dependent endocytosis in non-small cell lung cancer positive for HER2 mutations.

Journal: British journal of cancer

Published: November 27, 2024

NECTIN4 regulates the cell surface expression of CD155 in non-small cell lung cancer cells and induces tumor resistance to PD-1 inhibitors.

NECTIN4 regulates the cell surface expression of CD155 in non-small cell lung cancer cells and induces tumor resistance to PD-1 inhibitors.

Journal: Cancer immunology, immunotherapy : CII

Published: November 26, 2024

Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer.

Bevacizumab for Brain Radiation Necrosis in Patients With Nonsquamous Nonsmall Cell Lung Cancer.

Journal: Clinical lung cancer

Published: March 17, 2024

Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review.

Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review.

Journal: Thoracic cancer

Published: December 04, 2023

Osimertinib readministration for central nervous system metastases in non-small cell lung cancer positive for EGFR activating mutations.

Osimertinib readministration for central nervous system metastases in non-small cell lung cancer positive for EGFR activating mutations.

Journal: Respiratory investigation

Published: November 18, 2023

YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells.

YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells.

Journal: Biochemical and biophysical research communications

Published: September 05, 2023

TIP60 is required for tumorigenesis in non-small cell lung cancer.

TIP60 is required for tumorigenesis in non-small cell lung cancer.

Journal: Cancer science

Published: November 09, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026